Pallimed Recalls Diazepam Injectable Due to Sterility Assurance Concerns
Pallimed Solutions is recalling Diazepam Injectable vials because FDA inspections raised concerns about quality control procedures that impacted sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable drug, which poses a risk of serious injury or death from infection, fitting the 'Severe' criteria for significant injury reports or high-risk defects.
Plain-English summary
Pallimed Solutions Pharmacy in Woburn, Massachusetts, is recalling Diazepam Injectable. The recall involves 7 vials of the compounded medication. The distribution pattern is listed as nationwide, and the recall covers all lots within their expiry dates.
The recall was initiated due to a lack of assurance of sterility. FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance. The agency has classified this recall as Class II.
Consumers and healthcare providers should stop using the affected Diazepam Injectable vials and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Diazepam Injectable, compounded by Pallimed Solutions Pharmacy, Woburn, MA
- Manufacturer
- Pallimed Solutions
- Category
- Drug — Injectable
- Affected units
- 7
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 25 recalled by Pallimed Solutions under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 25 products in this recall →Related recalls
Same manufacturer · Pallimed Solutions
See all →- SeverePallimed Solutions Recalls Atropine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-08-21
- SeverePallimed Solutions Recalls Trimix Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-08-21
- SevereQuadmix Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-08-21
- SeverePallimed Acetylcysteine Ophthalmic Solution Recalled for Sterility Concerns
FDA (Drugs) · 2013-08-21
- SeverePallimed Solutions Recalls Testosterone Injection Due to Sterility Concerns
FDA (Drugs) · 2013-08-21
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereFDA Recalls Quadmix Custom Injectable Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-05-01
- SevereFDA Recalls Triamcinolone Diacetate Injectable Due to Sterility Concerns
FDA (Drugs) · 2013-05-01
- SevereFDA Recalls Methylcobalamin and Folic Acid Injectables Due to Sterility Concerns
FDA (Drugs) · 2013-05-01
- SevereBetamethasone Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2013-05-01
- SeverePharm D Solutions Recalls Pyridoxine Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SevereQuadMix Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2013-05-01